TD52
TD52 is an orally bioavailable Erlotinib derivative that functions as an inhibitor of CIP2A. It acts indirectly by disrupting Elk1 binding to the CIP2A promoter, thereby reducing CIP2A expression. This small molecule is used in cancer research, particularly in studies investigating EGFR signaling and tumor growth in both cellular and animal models.
Product Specifications
CAS Number
1798328-24-1
Field of Research
Cell Biology, Metabolism Research, Signal Transduction
Purity
99.50% (May vary between batches)
Smiles
C#Cc1cccc (Nc2nc3ccccc3nc2Nc2cccc (c2) C#C) c1
Molecular Formula
C24H16N4
Molecular Weight
360.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15110481 1 Vial
Lentiviral human DNM1L shRNA (UAS) - Lentiviral human DNM1L shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details 
132984-ML405 100 µL
SAV1 (Protein Salvador Homolog 1, SAV, 45kD WW Domain Protein, WW45, hWW45, WWP4) (MaxLight 405) discontinued
Sign In for Pricing
View Details 